The rate of malignancy in IBD patients in Crete is 4.5%. CD disease location and behavior are associated with the development of malignancies. No association with biologics and/or IMMs previous exposure was found. Moreover, initiation of biologics or IMMs after cancer diagnosis was not associated with an adverse impact either on survival or on cancer recurrence.
Foteinogiannopoulou et al. (Wed,) studied this question.